Hemorrhagic Fever, Ebola

Vaccines and Antiviral Agents
Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses
Peter Pushko, Joan Geisbert, Michael Parker, Peter Jahrling, Jonathan Smith
Pathogenesis and Immunity
Passive Transfer of Antibodies Protects Immunocompetent and Immunodeficient Mice against Lethal Ebola Virus Infection without Complete Inhibition of Viral Replication
Manisha Gupta, Siddhartha Mahanty, Mike Bray, Rafi Ahmed, Pierre E. Rollin
Vaccines and Antiviral Agents
Protection from Ebola Virus Mediated by Cytotoxic T Lymphocytes Specific for the Viral Nucleoprotein
Julie A. Wilson, Mary Kate Hart
Virus-Cell Interactions
Mutational Analysis of the Putative Fusion Domain of Ebola Virus Glycoprotein
Hiroshi Ito, Shinji Watanabe, Anthony Sanchez, Michael A. Whitt, Yoshihiro Kawaoka
Pathogenesis and Immunity
Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection
Toshiaki Maruyama, Luis L. Rodriguez, Peter B. Jahrling, Anthony Sanchez, Ali S. Khan, Stuart T. Nichol, C. J. Peters, Paul W. H. I. Parren, Dennis R. Burton
Pathogenesis and Immunity
Ebola Virus Selectively Inhibits Responses to Interferons, but Not to Interleukin-1β, in Endothelial Cells
Brian H. Harcourt, Anthony Sanchez, Margaret K. Offermann

Pages